TY - JOUR
T1 - Identification of potential genetic causal variants for rheumatoid arthritis by whole-exome sequencing
AU - Li, Ying
AU - Leung, Elaine Lai Han
AU - Pan, Hudan
AU - Yao, Xiaojun
AU - Huang, Qingchun
AU - Wu, Min
AU - Xu, Ting
AU - Wang, Yuwei
AU - Cai, Jun
AU - Li, Runze
AU - Liu, Wei
AU - Liu, Liang
N1 - Publisher Copyright:
© Li et al.
PY - 2017
Y1 - 2017
N2 - Rheumatoid arthritis (RA) is a highly prevalent chronic autoimmune disease. However, genetic and environmental factors involved in RA pathogenesis are still remained largely unknown. To identify the genetic causal variants underlying pathogenesis and disease progression of RA patients, we undertook the first comprehensive whole-exome sequencing (WES) study in a total of 124 subjects including 58 RA cases and 66 healthy controls in Han Chinese population. We identified 378 novel genes that were enriched with deleterious variants in RA patients using a gene burden test. The further functional effects of associated genetic genes were classified and assessed, including 21 newly identified genes that were involved in the extracellular matrix (ECM)-receptor interaction, protein digestion and absorption, focal adhesion and glycerophospholipid metabolism pathways relevant to RA pathogenesis. Moreover, six pathogenic variants were investigated and structural analysis predicted their potentially functional alteration by homology modeling. Importantly, five novel and rare homozygous variants (NCR3LG1, RAP1GAP, CHCHD5, HIPK2 and DIAPH2) were identified, which may exhibit more functional impact on RA pathogenesis. Notably, 7 genes involved in the olfactory transduction pathway were enriched and associated with RA disease progression. Therefore, we performed an efficient and powerful technique WES in Chinese RA patients and identifie d novel, rare and common disease causing genes that alter innate immunity pathways and contribute to the risk of RA. Findings in this study may provide potential diagnostic tools and therapeutic strategies for RA patients.
AB - Rheumatoid arthritis (RA) is a highly prevalent chronic autoimmune disease. However, genetic and environmental factors involved in RA pathogenesis are still remained largely unknown. To identify the genetic causal variants underlying pathogenesis and disease progression of RA patients, we undertook the first comprehensive whole-exome sequencing (WES) study in a total of 124 subjects including 58 RA cases and 66 healthy controls in Han Chinese population. We identified 378 novel genes that were enriched with deleterious variants in RA patients using a gene burden test. The further functional effects of associated genetic genes were classified and assessed, including 21 newly identified genes that were involved in the extracellular matrix (ECM)-receptor interaction, protein digestion and absorption, focal adhesion and glycerophospholipid metabolism pathways relevant to RA pathogenesis. Moreover, six pathogenic variants were investigated and structural analysis predicted their potentially functional alteration by homology modeling. Importantly, five novel and rare homozygous variants (NCR3LG1, RAP1GAP, CHCHD5, HIPK2 and DIAPH2) were identified, which may exhibit more functional impact on RA pathogenesis. Notably, 7 genes involved in the olfactory transduction pathway were enriched and associated with RA disease progression. Therefore, we performed an efficient and powerful technique WES in Chinese RA patients and identifie d novel, rare and common disease causing genes that alter innate immunity pathways and contribute to the risk of RA. Findings in this study may provide potential diagnostic tools and therapeutic strategies for RA patients.
KW - Chinese population
KW - Genetic causal variants
KW - Homology modeling
KW - Rheumatoid arthritis
KW - Whole-exome sequencing
UR - http://www.scopus.com/inward/record.url?scp=85038415459&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85038415459&partnerID=8YFLogxK
U2 - 10.18632/oncotarget.22630
DO - 10.18632/oncotarget.22630
M3 - Article
C2 - 29340042
AN - SCOPUS:85038415459
SN - 1949-2553
VL - 8
SP - 111119
EP - 111129
JO - Oncotarget
JF - Oncotarget
IS - 67
ER -